Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be entitled to payments based on a ...

Takeda regains a majority of XOMA Royalty's royalty interest in mezagitamab (TAK-079) -- XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine ...

Animal manure is not just a waste problem anymore. A new scientific review shows that when livestock manure is turned into biochar through controlled ...

Looking at 20 years of data from Stone X shows how 2025 and 2008 have elevated levels in phosphate pricing relative to corn price. One time spot pricing in New Orleans broke the historic high, however ...

Taking drops of a medical dye is trending in wellness and biohacking circles. Some influencers claim it boosts longevity and brain health. Scientists say the hype has gotten ahead of the research.

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Chemicals industry for Wednesday, December 17, 2025. Let’s take ...

DNA methylation involves adding a methyl group to DNA, which may influence gene expression and affect health aspects like childhood development and aging. Lifestyle factors, especially diet, may ...